Product Name : | Thymosin alpha-1 | ||
Cas No. : | 62304-98-7 | State : | |
Molecular Formula : | Purity/Specification : | 99.1% | |
Boiling Point : | Storage : | Minimize open air exposure, store in a cool dry place,Keep this product out of the reach of children. |
The right place to buy Thymosin alpha-1 peptide raw powder as research chemical with lab-test quality, well packing and shipping from china to worldwide. Each batch may be tested in vials by institutions appointed by our clients,janoshik.com for example , in that the quality is guaranteed.
Keep in mind that updates on pharmaceuticals may occure any time , and it is advisable that the information provided here should not be relied upon or used as the sole basis for making decisions without consulting primary, more accurate, more complete or more timely sources of information.
Please refer to our Terms of Service prior to buy Thymosin alpha-1 peptide raw powder either in vials or bags.Please be noted that this product is sold as a pure compound for research purposes only and is NOT meant for use as a dietary supplement.
Thymosin α1 is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene.
It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Unlike β thymosins, to which it is genetically and chemically unrelated, thymosin α1 is produced as a 28-amino acid fragment, from a longer, 113-amino acid precursor, prothymosin α.
Thymosin alpha-1, often referred to as Tα1, is a naturally occurring peptide found in the thymus gland, a crucial organ for the development and maintenance of the immune system. This peptide plays a significant role in supporting and modulating the immune response, which is essential for protecting the body against infections and diseases.
The primary benefit of thymosin alpha-1 lies in its ability to enhance immune function. The immune system is a complex network of cells, tissues, and organs that work together to defend the body against harmful pathogens, such as bacteria, viruses, and fungi. Thymosin alpha-1 helps regulate and strengthen this defense mechanism, promoting a more effective response to potential threats.
One notable advantage of thymosin alpha-1 is its ability to stimulate the production of T cells. T cells are a type of white blood cell that plays a central role in the immune system by recognizing and attacking infected or abnormal cells. By promoting the generation of T cells, thymosin alpha-1 enhances the body’s ability to identify and eliminate harmful invaders, contributing to a more robust immune system.
Another crucial aspect of thymosin alpha-1’s benefits is its role in modulating the balance of immune responses. It helps regulate the delicate equilibrium between the various components of the immune system, ensuring an appropriate and controlled reaction to different threats. This modulation is essential for preventing excessive inflammation, which can lead to chronic conditions and autoimmune disorders.
Thymosin alpha-1 has shown promise in supporting individuals with compromised immune systems, such as those undergoing cancer treatments or suffering from chronic infections. In these cases, the immune system may be weakened, making the body more susceptible to infections. Thymosin alpha-1 can aid in restoring and strengthening the immune response, providing an additional layer of defense for individuals facing immune challenges.
In addition to its immune-boosting properties, thymosin alpha-1 has demonstrated anti-inflammatory effects. Inflammation is a natural response to injury or infection, but chronic inflammation can contribute to various health issues, including cardiovascular diseases, arthritis, and other chronic conditions. Thymosin alpha-1 helps regulate the inflammatory response, promoting a balanced and controlled reaction to stimuli, which can be beneficial in managing chronic inflammatory conditions.
Furthermore, thymosin alpha-1 has been explored for its potential in addressing respiratory infections. The peptide has shown the ability to enhance the function of the respiratory system, making it a potential candidate for individuals prone to respiratory infections or those recovering from such conditions. This aspect of thymosin alpha-1’s benefits is particularly relevant in the context of respiratory illnesses, where maintaining optimal lung function is crucial for overall health.
The peptide’s versatility extends to its role in supporting wound healing. By promoting a balanced immune response and facilitating the regeneration of damaged tissues, thymosin alpha-1 contributes to the efficient healing of wounds and injuries. This aspect of its benefits is valuable not only for individuals with acute injuries but also for those with chronic wounds or conditions that affect the healing process.
Moreover, thymosin alpha-1 has been studied for its potential in addressing viral infections. While not a direct antiviral agent, the peptide’s ability to modulate the immune response can be advantageous in the context of viral infections. It may help the immune system mount a more effective defense against viruses, potentially reducing the severity and duration of viral illnesses.
In summary, thymosin alpha-1 is a naturally occurring peptide with a wide range of health benefits, primarily centered around its ability to enhance and modulate the immune system. From supporting T cell production to regulating inflammation and aiding in wound healing, thymosin alpha-1 plays a crucial role in maintaining overall health and resilience against infections and diseases. While ongoing research continues to uncover additional facets of its therapeutic potential, the current understanding highlights thymosin alpha-1 as a promising candidate for immune support and overall well-being.
Study links:
Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144173
Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study”
https://www.frontiersin.org/articles/10.3389/fimmu.2021.673693/full